The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey

Since the introduction of Cetuximab as a biological molecule against Epidermal Growth Factor Receptor (EGFR), its use in the cancers of head and neck region is widely explored. With the recognition that EGFR expression is associated with radioresistance and poor prognosis, incorporation of an anti-E...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sapna Krishnamurthy, Imtiaz Ahmed, Rohan Bhise, Bidhu K Mohanti, Atul Sharma, Thorsten Rieckmann, Claire Paterson, Pierluigi Bonomo
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2022-05-01
Colecção:Clinical and Translational Radiation Oncology
Assuntos:
Head and neck cancer
Cetuximab
Bio-radiotherapy
Chemoradiation
anti- EGFR
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2405630822000222
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados